GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » SymBio Pharmaceuticals Ltd (TSE:4582) » Definitions » Cyclically Adjusted Book per Share

SymBio Pharmaceuticals (TSE:4582) Cyclically Adjusted Book per Share : 円307.45 (As of Dec. 2024)


View and export this data going back to 2011. Start your Free Trial

What is SymBio Pharmaceuticals Cyclically Adjusted Book per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

SymBio Pharmaceuticals's adjusted book value per share for the three months ended in Dec. 2024 was 円91.574. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is 円307.45 for the trailing ten years ended in Dec. 2024.

During the past 12 months, SymBio Pharmaceuticals's average Cyclically Adjusted Book Growth Rate was -19.20% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was -17.10% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was -17.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of SymBio Pharmaceuticals was -17.10% per year. The lowest was -17.30% per year. And the median was -17.20% per year.

As of today (2025-05-30), SymBio Pharmaceuticals's current stock price is 円170.00. SymBio Pharmaceuticals's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2024 was 円307.45. SymBio Pharmaceuticals's Cyclically Adjusted PB Ratio of today is 0.55.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of SymBio Pharmaceuticals was 3.80. The lowest was 0.33. And the median was 0.81.


SymBio Pharmaceuticals Cyclically Adjusted Book per Share Historical Data

The historical data trend for SymBio Pharmaceuticals's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SymBio Pharmaceuticals Cyclically Adjusted Book per Share Chart

SymBio Pharmaceuticals Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 672.91 539.34 454.91 380.50 307.45

SymBio Pharmaceuticals Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 360.27 342.80 324.11 307.45 -

Competitive Comparison of SymBio Pharmaceuticals's Cyclically Adjusted Book per Share

For the Drug Manufacturers - Specialty & Generic subindustry, SymBio Pharmaceuticals's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SymBio Pharmaceuticals's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, SymBio Pharmaceuticals's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where SymBio Pharmaceuticals's Cyclically Adjusted PB Ratio falls into.


;
;

SymBio Pharmaceuticals Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, SymBio Pharmaceuticals's adjusted Book Value per Share data for the three months ended in Dec. 2024 was:

Adj_Book= Book Value per Share /CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=91.574/110.7000*110.7000
=91.574

Current CPI (Dec. 2024) = 110.7000.

SymBio Pharmaceuticals Quarterly Data

Book Value per Share CPI Adj_Book
201503 810.864 97.900 916.881
201506 782.406 98.400 880.207
201509 738.680 98.500 830.171
201512 547.272 98.100 617.564
201603 469.863 97.900 531.296
201606 527.127 98.100 594.831
201609 495.264 98.000 559.446
201612 471.492 98.400 530.429
201703 445.258 98.100 502.447
201706 391.597 98.500 440.099
201709 232.142 98.800 260.102
201712 239.743 99.400 266.997
201803 230.178 99.200 256.862
201806 223.218 99.200 249.095
201809 242.383 99.900 268.587
201812 237.951 99.700 264.204
201903 217.024 99.700 240.968
201906 222.730 99.800 247.056
201909 158.813 100.100 175.630
201912 166.576 100.500 183.482
202003 157.256 100.300 173.562
202006 164.750 99.900 182.561
202009 142.017 99.900 157.370
202012 122.006 99.300 136.013
202103 116.144 99.900 128.700
202106 115.904 99.500 128.950
202109 130.399 100.100 144.207
202112 175.783 100.100 194.397
202203 178.316 101.100 195.248
202206 212.278 101.800 230.837
202209 224.199 103.100 240.726
202212 215.246 104.100 228.893
202303 215.450 104.400 228.451
202306 210.742 105.200 221.760
202309 193.071 106.200 201.252
202312 170.891 106.800 177.131
202403 156.378 107.200 161.484
202406 140.727 108.200 143.979
202409 112.544 108.900 114.404
202412 91.574 110.700 91.574

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


SymBio Pharmaceuticals  (TSE:4582) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

SymBio Pharmaceuticals's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=170.00/307.45
=0.55

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of SymBio Pharmaceuticals was 3.80. The lowest was 0.33. And the median was 0.81.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


SymBio Pharmaceuticals Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of SymBio Pharmaceuticals's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


SymBio Pharmaceuticals Business Description

Traded in Other Exchanges
Address
5-23-7 Shimbashi, San-Ei Building, 8th Floor, Minato-ku, Tokyo, JPN, 105-0004
SymBio Pharmaceuticals Ltd is a biopharmaceutical company engaged in manufacturing and commercializing drugs for oncology, hematology, and pain management.

SymBio Pharmaceuticals Headlines

No Headlines